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Abstract Over the last decade, several protein kinases
inhibitors have reached the market for cancer chemothe-
rapy. The kinomes of pathogens represent potentially
attractive targets in infectious diseases. The functions of
the majority of protein kinases of Plasmodium falciparum,
the parasitic protist responsible for the most virulent form
of human malaria, remain unknown. Here we present a
thorough characterisation of PfTKL3 (PF13_0258), an
enzyme that belongs to the tyrosine kinase-like kinase
(TKL) group. We demonstrate by reverse genetics that
PfTKL3 is essential for asexual parasite proliferation in
human erythrocytes. PfTKL3 is expressed in both asexual
and gametocytes stages, and in the latter the protein co-
localises with cytoskeleton microtubules. Recombinant
PfTKL3 displays in vitro autophosphorylation activity and
is able to phosphorylate exogenous substrates, and both
activities are dramatically dependent on the presence of an
N-terminal ‘‘sterile a-motif’’ domain. This study identiﬁes
PfTKL3 as a validated drug target amenable to high-
throughput screening.
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Introduction
Malaria is a major public health problem affecting
approximately 40% of the world population [1]. The vast
majority of fatal cases are caused by Plasmodium falci-
parum, one of the ﬁve species of malaria parasites that
infect humans. The number of deaths due to malaria dou-
bled in the 2 decades preceding the millennium, the
primary reason being the spread of parasite resistance to
antimalarial drugs, especially chloroquine [2]. Artemisinin
combination therapy (ACT) helped reverse this trend, but
reduced artemisinin sensitivity was recently reported in
southeast Asia [3, 4]. Therefore, development of antimal-
arials with novel modes of action is an urgent priority.
Protein phosphorylation is recognised as a major
mechanism by which virtually every activity of a eukary-
otic cell is regulated. Eukaryotic protein kinases (ePKs) are
distributed in seven major groups (CK1, AGC, CamK,
CGMC, TK, TKL and STE) on the basis of phylogenetic
analysis of catalytic domains; the enzymes that do not
belong to any of these groups are classiﬁed as ‘‘OPK’’
(‘‘other protein kinases’’) [5]. Based on (1) the success of
protein kinase inhibitors in the treatment of various cancers
[6] and the prospect of the use of such molecules in
microbial diseases [7], and (2) the documented divergences
between mammalian and Plasmodium protein kinases
(PKs) (reviewed in [8]), the kinome of the parasite has been
proposed as an attractive target for pharmacological
intervention [9]. The &85 enzymes that constitute the
P. falciparum kinome include several ‘‘orphan’’ kinases
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ther within the seven major ePK groups nor with ePKs in
the OPK group [10]. In contrast, Plasmodium ‘‘semi-
orphan’’ kinases clearly do belong to one of the ePK groups
or speciﬁc OPK families, but orthology to individual
enzymes within these groups/families in other organisms
cannot be assigned.
Plasmodium falciparum members of the CK1, CMGC,
AGC or CamK groups, as well as plasmodial PKs related
to OPKs such as the NIMA-related kinases, have all been
the subject of functional investigations (reviewed in [8]).
In contrast, the Plasmodium TKLs (Tyrosine kinase-like)
have been largely understudied. TKL amino acid
sequences are related to those of tyrosine kinases (TKs), a
group that is not represented in the parasite’s kinome.
Some TKL families, such as RAFs and MLKs, are
MAP3K (the core module of MAPK pathways consists of
a cascade of three kinases, MAP3K [MEKK], MAP2K
[MEK] and MAPK). Others like IRAK and RIPK mem-
bers are involved in immune response signalling, while
others such as LIM kinase are regulators of the cyto-
skeleton. The plasmodial kinome was reported to contain
ﬁve TKL homologues [10], but the only published report
on a TKL concerns the identiﬁcation of one such kinase
(PlasmoDB identiﬁer PF11_0220) as secreted to the
extracellular medium [11].
Our interest in plasmodial MAPK pathways prompted us
to engage in the characterisation of the P. falciparum TKL
group, as by analogy with other systems (see above) they
represent potential MAP3K candidates. Here, we present a
reﬁned phylogeny of the P. falciparum TKL group that
reduces the number of PfTKLs from 5 to 4, and we proceed
to a detailed characterisation of one of these four enzymes,
PfTKL3. We demonstrate that an accessory ‘‘Sterile
a-Motif’’ (SAM) domain present on the PfTKL3 polypep-
tide mediates oligomerisation and is crucial for kinase
activity in vitro. We provide evidence that PfTKL3 is
essential for completion of the erythrocytic asexual cycle,
thus validating the enzyme as a potential target for anti-
malarial intervention.
Materials and methods
Bioinformatics
Sequences alignment was performed using T-Coffee
(http://www.ebi.ac.uk/Tools/t-coffee/); when necessary the
aligned sequences were edited manually. Shading of resi-
dues was performed using GeneDoc and the bootstrap
neighbour-joining phylogenetic tree generated with the
MEGA software 4 [12].
Parasite culture
Asexual parasites of the P. falciparum 3D7 clone were
grown as described [13] and used as recipients in all
transfection experiments. Gametocytes were prepared
according to the protocol of Carter et al. [14].
Plasmid construction
PfTKL3 KDWT
A 1,155-bp DNA fragment [nucleotides 4,213–5,367 of the
predicted coding sequence of PfTKL3 (PF13_0258)] was
ampliﬁed by PCR from a P. falciparum asexual cDNA
library (strain IT04), using primers 560 and 541 (see
Supplemental Table 1) containing BamH1 and Sal1 sites,
respectively. The ampliﬁed fragment was cloned into
pET28a between the BamH1 and Sal1 restriction sites.
PfTKL3 dead mutant-pET28a
Mutations of the speciﬁc residues (K ? M and D ? N)
were introduced following the method of [15] by two
rounds of PCR with speciﬁc primers (K ? M: primers 688
and 689, D ? N: primers 652 and 653) containing the
mutations (see Supplemental Table 1).
PfTKL3 Sam-KD and SAM domain mutagenesis
The region spanning nucleotides 3,922–5,367 of the
PfTKL3 coding sequence, which includes the region cod-
ing for the SAM and the kinase domains, was PCR-
ampliﬁed from a P. falciparum asexual cDNA library using
primers 690 and 541, containing BamH1 and Sal1 restric-
tion sites, respectively (see Supplemental Table 1). The
insert was cloned into pET28a plasmid using the same
procedure as the kinase domain. Two residues, H35 and
V54 (numbering is from the start of the cloned SAM
domain) within the SAM domain, were mutated to Glu by
two rounds of PCR using primers (ﬁrst round: V54E:
primers 733 and 734, H35E: primers 779 and 780) con-
taining the appropriate mutation and second round: primers
690 and 541. The mutants were cloned into pET28a plas-
mid described for the wild type.
pCAM-BSD-PfTKL3
A 561-bp DNA fragment (nucleotides 4,540–5,100 of the
PfTKL3 ORF) was ampliﬁed by PCR from P. falciparum
genomic DNA using primers 501 and 549 (with BamH1
and Not1 restriction sites, respectively) and was inserted
into pCAM-BSD [16].
3356 A. Abdi et al.pCAM-BSD-PfTKL3-TAG
The pCAM-BSD-TAG vectors were generated by intro-
ducing the sequence coding for GFP or double HA (dHA),
and the 30 UTR of the P. berghei dhfr-ts gene into the mul-
tiple cloning site of pCAM-BSD (Fig. 3a). The 30 end of the
PfTKL3coding region (621 bp omitting the stop codon) was
ampliﬁed by PCR from genomic DNA, using primers 577
and578withPst1orBamH1restrictionsites, which allowed
insertion of the ampliﬁed product into pCAM-BSD-TAG.
Cloning of the SAM domain
The sequence encoding the SAM domain (3,922–4,131 of
the ORF) was PCR ampliﬁed using primers 690 and 737
and cloned into pET28a, pGEX4T3, or pMAL-c2E as
described above. A stop codon was included in the reverse
primer sequence.
Expression and puriﬁcation of recombinant proteins
All expression vectors were transformed into Rosetta2
(DE3)pLysS cells (Stratagene). pET28-transformed cells
were grown in LB media containing 10 lg/ml of kanamycin
and 34 lg/ml of chloramphenicol, and expression was
inducedwith1 mMIPTGat20Covernight.Fortheplasmids
based on the pGEX4T3 and pMAL-c2E vectors, 100 lg
ampicillin was used instead of kanamycin, and induction was
with 0.2 mM IPTG. Puriﬁcation of His6-tagged proteins was
performed on Ni-NTA agarose beads (Qiagen), while the
GST-andMBP-taggedproteinswerepuriﬁedonglutathione-
(Sigma) and amylose- (NEB) agarose beads.
cDNA preparation and RT–PCR
Total RNA was extracted from parasite pellets using
TRIzol lysis solution (Invitrogen). DNase treatment of
RNA samples prior to RT-PCR was performed by incu-
bation at 37C for 30 min with RQ1 RNase-free DNase
(Promega). The DNase was inactivated by incubation at
65C for 10 min. To generate cDNA, RETROscript
 Kit
(Ambion) was used; 2 lg of RNA was used with random
decamers in a PCR with or without reverse transcriptase
following the manufacturer’s protocol. The cDNA was
then used in nested PCR using primers 560 and 541 (ﬁrst
round) and 501 and 541 (second round). The PfTKL2
kinase domain (loading control) was ampliﬁed from the
cDNA in a single step PCR using primers 935 and 505.
Western blotting
Parasite extracts: Parasite pellets obtained by saponin lysis
from synchronised asexual cultures and gametocytes
cultures were incubated in lysis buffer [50 mM Tris,
pH 8.0, 300 mM NaCl, 0.1 mM EDTA, 0.5% Triton,
1 9 protease inhibitors cocktail (Roche)] for 30 min on
ice, brieﬂy sonicated and spun at 14,000 rpm for 10 min at
4C; 10 lg from the supernatants was boiled in Laemmli
sample buffer, run on a 8% SDS-PAGE gel and transferred
to nitrocellulose (transfer buffer: 25 mM Tris, pH8.3,
192 mM glycine, 20% methanol and 0.025% SDS).
Membranes were blocked in 5% skimmed milk (Bio-Rad)
and PBS containing 0.25% Tween 20 for 1 h at room
temperature. Washes were performed using PBS contain-
ing 0.25% Tween 20. Rat anti-HA mAb,clone 3F10, Roche
(1:500), mouse anti-GFP, mAb Roche (1:500) and chicken
anti-Rat-HRP, Abcam (1:2,500) and rabbit anti-mouse-
HRP (1:5,000) were used. Detection was performed by
chemoluminescence using the ECL system (Perkin Elmer).
In the case of anti-GFP, 1 volume of SuperSignal West
Femto Substrate (Pierce Biotechnology) and 2 volumes of
Perkin-Elmer detection reagent were mixed for detection of
PfTKL3-GFP signal. Rabbit anti-PfGR (1:15,000) and anti-
P. falciparum thioredoxin peroxidase 1 (1:4,000) antibod-
ies (gift from Prof. Sylke Muller) were used as loading
control.
Recombinant proteins: Transfer of the recombinant
protein was performed using the semi-dry cell (Bio-Rad).
Rabbit Anti-GST (Sigma) (1:10,000), rabbit anti-MBP
(NEB), (1:10,000) and rabbit anti-His6 (Santa Cruz)
(1:1,000) primary antibodies were used. Anti-rabbit IgG-
HRP (Sigma) (1: 10,000) secondary antibody was used.
Parasite transfection
Transfections were carried out by electroporation of ring
stage 3D7 parasites with 50–100 lg of plasmid DNA,
according to [16]. Blasticidin (Calbiochem) was added to a
ﬁnal concentration of 2.5 lg/ml 48 h post transfection.
Genotype characterisation
PCR
For the detection of integration of the pCAM-BSD-
PfTKL3 plasmid into genomic DNA, the following primers
were used (see Fig. 2a for numbering and see Supple-
mental Table 1 for sequences): 560 (forward) and 803
(reverse) diagnostic for wild-type locus, 167 (forward) and
168 (reverse) for episome, 560 and 168 for 50 integration,
and 167 and 803 for 30 integration. For detection of inte-
gration of the pCAM-BSD-PfTKL3-GFP/HA plasmid, the
following primers were used (see Fig. 3a for numbering
and see Supplemental Table 1 for the sequences): 560 and
803 for wild type, 167 and 803 for 30 integration, 560 and
806/639 (reverse for GFP and HA-tags respectively) for 50
A Plasmodium tyrosine kinase-like kinase 3357integration, and 167 and 806 (or 168 in the case of HA) for
episome.
Southern blotting
Genomic DNA was extracted from parasite pellets prepared
from the transfectant lines using QIAamp
 DNA mini kit
(Qiagen). The DNA was digested with Nsi1, separated on a
0.8% agarose gel and transferred to a Hybond N membrane
(Amersham). Probing with DNA probes was carried out
using the Amersham AlkPhos direct labelling and detection
kit.Brieﬂy,100 ngofaDNA fragment(either the fragments
inserted into the knock-out or tagging plasmids) was label-
led and hybridised with the membrane overnight at 55C.
Labelling of the probe, washes of the membrane, and
detectionwereperformedasdescribedinthemanufacturer’s
protocol. The membrane was stripped with 0.1%SDS (in
dH2O)at55Cforanhourandreprobedwithaprobederived
from the BSD coding region.
Microscopy
Live parasites expressing GFP-tagged PfTKL3 and para-
sites ﬁxed with 4% paraformaldehyde were used. Images of
live parasites were captured directly using a Delta vision
deconvolution ﬂuorescence microscope (X100 Olympus
IX-70 objective). For ﬁxed parasites, images were obtained
after counterstaining (1) with mouse anti-Pfs16 antibody
(1:50) (a kind gift from Pietro Alano) or mouse anti-
chicken-brain-tubulin (1:250) (clone DM1A, purchased
from Sigma) and (2) with 4,6-diamidino-2-phenylindole,
and a TRITC-conjugated goat anti-mouse IgG1 secondary
antibody (1:250) (Southern Biotech, Birmingham, AL).
Kinase assays
Kinase assays were performed in a 30-ll reaction mixture
containing the recombinant (either wild-type or mutant)
protein, 5 lg of substrate (myelin basic protein, histone
H1, a-casein and b-casein), 20 mM MgCl2, 2 mM MnCl2,
10 lM ATP (containing 0.075 MBq [c-32P]), 10 mM NaF
and 10 mM b-glycerophosphate in 20 mM Tris (pH 7.5).
The mixture was incubated for 30 min at 30C, and the
reaction was stopped by adding Laemmli buffer and heat-
ing at 100C for 3 min. The samples were resolved by
SDS-PAGE gel, and the gel was stained with Coomassie
blue, dried and incubated with X-ray ﬁlm (Kodak) and
subjected to autoradiography.
SAM domain expression and pull down assays
The SAM domain coding sequence was cloned into
pET28a, pGEX4T3 and pMAL-c2E and expressed in
Rosetta2(DE3)pLysS E. coli. pGEX4T3 and pMAL-c2E
were also transformed into the same cells and induced for
expression of GST and MBP alone. The recombinant
proteins were puriﬁed using Ni-NTA agarose beads, glu-
tathione beads or amylose beads, respectively. For pull-
down assays, puriﬁed MBP-SAM was incubated while
shaking with puriﬁed GST-SAM for 1 h at 4C. As a
control, MBP-SAM was similarly incubated with GST or
lysis buffer (50 mM Tris, 100 mM NaCl, 0.1 mM EDTA,
pH 7.4). Glutathione beads pre-washed with the lysis buffer
were added to the mixture and incubated for another 1 h at
4C. Similarly, puriﬁed GST-SAM was incubated as above
with MBP-SAM, MBP alone or lysis buffer. Amylose
beads were added to the mixture and incubated as above.
The beads were centrifuged at 1,500 rpm for 2 min,
washed three times (washing buffer: 50 mM Tris, 300 mM
NaCl, 0.1 mM EDTA, pH 8.0) and eluted with wash buffer
containing either 15-mM reduced glutathione or 12-mM
maltose. Eluted proteins were boiled in Laemmli buffer,
resolved on SDS-PAGE gel, transferred to nitrocellulose
paper and probed the paper with both anti-GST (rabbit,
Sigma) and anti-MBP (rabbit, NEB) antibodies.
Results
Bioinformatic analysis
Phylogenetic analysis of the P. falciparum kinome [10]
identiﬁed ﬁve sequences clustering with the human TKL
group, with PlasmoDB identiﬁers PFB0520w, PF11_0220,
PF13_0258, PFF1145c, and PF14_0320; the latter was a
relative outlier, branching out close to the base of the TKL
cluster. A more reﬁned analysis of kinase domains
including several additional human sequences of the TKL
group (Fig. 1a) now leads us to conclude that PF14_0320
cannot be classiﬁed as a TKL, but conﬁrms that
PFB0520w, PF11_0220, PF13_0258, PFF1145c (thereafter
called PfTKL1, PfTKL2, PfTKL3 and PfTKL4, respec-
tively) do indeed belong to the TKL group. PfTKL1 and
PfTKL3 cluster closely together and have similar accessory
functional domains within their N-terminal extension (see
below). The present study focuses on PfTKL3
(PF13_0258).
The pftkl3 gene is predicted to comprise a single exon
located on chromosome 13, encoding a 1807-residue
protein. The kinase catalytic domain (Pfam entry PF00536,
E-value 1.4
-43) is located in the C-terminal region (residues
1407-1789). The long N-terminal extension comprises the
following domains, starting from the N-terminus (Fig. 1b):
(1) a putative PEXEL motif (Plasmodium Export Element,
RXLX[EQD]) mediating trafﬁcking to the host erythrocyte
(residues 25-RNLDD-29); (2) a potential 14-3-3 mode II
3358 A. Abdi et al.binding motif (RX[YF]Xp[TS]xP) (55-RRFKTEP-61); (3)
two tandem putative MORN motifs (Membrane Occupation
and Recognition Nexus) motif (residues 475–497 and 498–
519); Pfam entry PF02493, E-value 98); and (4) a putative
SAM domain (residues 1,311–1,372; Pfam entry PF00532,
E-value 1.8
-05). MORN motifs are involved in membrane
interactions, while SAM domains are protein-protein inter-
action mediators. The E-value for the MORN motif is low,
but sequence alignment with proteins that contain multiple
MORN motifs, such as Arabidopsis thaliana phosphatidyl-
inositol kinase, conﬁrms the presence of a MORN motif in
PfTKL3 and orthologs (Supplemental Figure S1A).
The pftkl3 gene is conserved in all the Plasmodium and
Cryptosporidium species (C. parvum and C. hominis) for
which genome sequence data are available. A homolog is
also present in Neospora caninum and Toxoplasma gondii
(gene identiﬁers; NCLIV_008190 and TGME49_053860
respectively). In T. gondii, the N-terminal extension is very
short in comparison to the other apicomplexan homo-
logues, and lacks the MORN and SAM motifs within the
extension. The N-terminal extensions of Plasmodium and
Cryptosporidium sequences share no similarity outside the
MORN and SAM motifs, with the exception of a highly
conserved stretch of unknown function located between the
MORN and SAM domains (Fig. 1b displays a schematic
representation of the orthologs, and Supplemental Fig. S1B
an alignment of the PEXEL, MORN and SAM motifs, the
conserved regions of unknown function and the kinase
catalytic domain). The potential 14-3-3 binding motif is
found only in the Plasmodium and Neospora sequences.
PfTKL3 plays a crucial role in erythrocytic schizogony
To investigate whether the enzyme plays an essential role
in erythrocytic schizogony, we attempted to disrupt the
pftkl3 locus using a single cross-over gene disruption
strategy that we previously used successfully for several
P. falciparum protein kinases [17–19]. A construct con-
taining the central part of the kinase domain coding region
and a blasticidin-resistance cassette was introduced into
3D7 parasites. Single cross-over recombination is expected
to disrupt the gene and yield two truncated, non-functional
copies (Fig. 2a). Two independent transfections were car-
ried out, and blasticidin-resistant populations were readily
obtained. Integration was monitored by PCR (Fig. 2b) and
Southern blot (Fig. 2c). Even after prolonged cultivation
(6 months), no integration was detected in the transgenic
lines. However, increasing PCR sensitivity by using high
concentrations of template DNA and 35 PCR cycles
allowed us in a few instances to detect a very weak band
diagnostic of integration event (data not shown), suggest-
ing that pftkl3 gene disruption is possible, but that the
parasites in which integration has occurred could not
overgrow the parasites that retain a wild-type pftkl3 locus.
This indicates that the modiﬁcation is either lethal or
causes a severe growth rate defect.
Fig. 1 Phylogeny and domain organisation of PfTKL3. a Phyloge-
netic tree of the kinase domain sequences from representatives of the
human (black) and P. falciparum (red) kinome families. The ﬁve
sequences identiﬁed as P. falciparum TKLs in Ref. [10] are
highlighted in yellow. b Schematic representation of PfTKL3
homologs in Apicomplexa
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modiﬁed pftkl3 locus if the modiﬁcation does not cause
loss of function, we generated parasite lines expressing the
endogenous PfTKL3 protein fused to green ﬂuorescent
protein (GFP) or a double hemaglutinin epitope (dHA;
Fig. 3a). PCR analyses showed that in transgenic popula-
tions integration had taken place by 8 weeks post
transfection and that the wild-type locus was lost in both
the GFP and dHA-tagged lines (Fig. 3b, c). The PCR result
was further conﬁrmed by Southern blot analysis in the case
of the GFP-tagged line (Fig. 3d). These results show that
the pftkl3 locus is accessible to homologous recombination.
Expression of epitope-tagged PfTKL3 in asexual culture
was ﬁrst conﬁrmed by using HA- and GFP-speciﬁc anti-
bodies in Western blot analyses. Total protein extracts from
saponin lysed parasite pellets were prepared from the dHA-
and GFP-tagged lines, each providing a negative control
for the other. Western blot analysis using a rat anti-HA
mAb consistently detected 250-, 130- and 95-kDa bands in
protein extracts prepared from the HA-tagged line, the
latter two bands presumably being C-terminal fragments
resulting from processing or degradation of HA-tagged
PfTKL3 (the predicted size of the PfTKL3 polypeptide is
212 kDa) (Fig. 3e). In some experiments a band of higher
molecular weight ([250 kDa) was also detected (data not
shown). An anti-GFP mAb detected a band of a relatively
larger size compared to the HA-tagged protein, as expected
from the sizes of the tags. No cross-reactivity between
extracts was detected for both antibodies, and equal loading
was ascertained with an antibody against P. falciparum
glutathione reductase (PfGR, PlasmoDB identiﬁer
PF14_0192).
PfTKL3 expression proﬁle
Microarray analysis detected PfTKL3 mRNA in all
stages of the asexual cycle, as well as in gametocytes and
sporozoites [20] (data available in PlasmoDB, www.
plasmodb.org). Nested RT-PCR using RNA extracted
from rings, trophozoites and schizonts conﬁrmed the
presence of PfTKL3 mRNA throughout the asexual cycle,
with mRNA abundance peaking at the schizont stage.
Fig. 2 Targeted gene
disruption of pftkl3. a Gene
disruption strategy. The
restriction enzyme (Nsi1) sites
used for Southern blot analysis
and the sizes of the expected
fragments are shown. The
arrows (dark bold) indicate the
location of primers used in PCR
analysis. BSD is a blasticidin-
resistance marker. b PCR
analysis. The amplicons are
diagnostic for: lane 1, episome;
lane 2, 30 boundary of integrated
plasmid; lane 3, 50 boundary of
integrated plasmid; lane 4, wild-
type locus. The numbers 560,
167, 168 and 803 represent the
primers used (sequences in
Supplemental Table 1).
c Southern blot analysis.
Genomic DNA from
untransfected (U) and
pCAM-BSD-PfTKL3
transfected (T) 3D7 parasites
was digested with Nsi1 and
probed with PfTKL3 (left panel)
and BSD (right panel) probes
3360 A. Abdi et al.Control reactions without reverse transcriptase did not
yield any signal, ruling out genomic DNA contamination.
Primers speciﬁc for PfTKL2, which is constitutively
expressed [11], were used to verify that all samples con-
tained equal amounts of mRNA (Supplemental Fig. S2A).
We used the parasite lines expressing tagged PfTKL3 to
monitor expression of the protein. Protein extracts were
prepared from rings, trophozoites, schizonts and gameto-
cytes of the PfTKL3-dHA and PfTKL3-GFP lines. Western
blot analysis using an anti-HA mAb detected a signal in all
extracts from PfTKL3-dHA parasites, while no signal was
observed in the control GFP-tagged line. An antibody
against P. falciparum thioredoxin peroxidase 1 (PfTPx,
PF14_0368) was used as a loading control. The PfTKL3/
PfTPx ratio was the highest in schizonts, somewhat lower in
trophozoites and very low in rings (Supplemental Fig. S2B).
Fluorescence microscopy
To gain further insight into the spatial-temporal expression
proﬁle of PfTKL3, the PfTKL3-GFP tagged line was
analysed microscopically. When live asexual synchronised
cultures were observed by ﬂuorescence microscopy, a GFP
signal was detected in schizonts and free merozoites
(Fig. 4). No signal was detected in rings and trophozoites
(not shown). In schizonts, the signal seems to be conﬁned
within the parasite (implying the putative PEXEL is not
functional) and to localise within structures forming a
Fig. 3 GFP- and HA-tagging of
the pftkl3 locus. a C-terminal
tagging strategy. The location of
PCR primers used for
genotyping is indicated by
numbered arrows. See the text
for details. b PCR analysis of
the GFP tagged locus: Genomic
DNA from untransfected and
transfected 3D7 parasites was
subjected to PCR analysis using
the primers numbered in a. The
amplicons are diagnostic for:
lane 1, episome; lane 2, wild
type; lane 3, 30 boundary of
integrated plasmid; lane 4, 50
boundary of integrated plasmid.
The numbers 560, 167, 168, 803
and 806 represent the primers
used (sequences in
Supplemental Table 1). c PCR
analysis of the HA-tagged locus.
This was performed as in b,
except the DNA was from
pCAM-BSD-PfTKL3dHA-
transfected parasites, and primer
639 was used instead of primer
806. d Southern blot analysis.
Genomic DNA from
untransfected (U) and pCAM-
BSD-PfTKL3GFP-transfected
(T) 3D7 parasites was digested
with Nsi1 and probed with a
pftkl3 probe. e Western blot
analysis. Protein extracts
(10 lg/lane) from dHA-tagged
(lane 1) and GFP-tagged (lane
2) lines were separated by SDS-
PAGE, transferred to
nitrocellulose and probed with
anti-GFP (left), anti-HA (right)
or anti-PfGR (bottom, loading
control) antibodies
A Plasmodium tyrosine kinase-like kinase 3361network that becomes extensive in mid and late schizont
stages. Our attempt to assign localisation of the protein to
known subcellular structures in the asexual stages was not
successful, partly due to the fact that the GFP signal
disappears after ﬁxing the cells, thus preventing immuno-
ﬂuorescence analysis. In free merozoites, the protein
appears to be localised in an elongated structure with
bulbous ends (see the enlarged merozoite in Fig. 4). All
stages of gametocyte development gave a GFP signal
(Fig. 5). In stage I, the protein appears to be evenly dis-
tributed in the cytoplasm (Fig. 5a), whereas in stage II, the
signal appears to start localising in discrete areas (Fig. 5b).
This becomes more apparent in stage III, where the signal
concentrates into a discrete, diamond-shaped area (Fig. 5c,
d). In some instances an extension appears to form tubular-
looking structures (Fig. 5e, f). In stages IV and V, this
becomes less prominent (Fig. 5g, h), and the signal is again
more evenly distributed, with thread-like structure along
the length of one side of the cell. IFA using an antibody
against Pfs16 (PFD0310w), a protein that resides within the
parasitophorous vacuole membrane, revealed that the GFP
signal is conﬁned within the gametocyte (Fig. 6a).
Since the GFP signal accumulates in thread-like struc-
tures along one side of the cell, we next investigated if this
is associated with the sub-pellicular membrane complex,
which has been described as having these characteristics
and is thought to anchor the microtubular cytoskeleton,
thereby maintaining the shape of gametocytes [21]. We
used an antibody against a-tubulin to counterstain game-
tocytes from the PfTKL3-GFP line (this was not possible
with asexual parasites, as the GFP signal was lost upon
ﬁxation, presumably because of lower amounts of PfTKL3
in asexual parasites than in gametocytes). This showed that
the GFP signal co-localises or closely associates with
microtubules in the early stages of the gametocytes
(Fig. 6b).
Regulation of recombinant PfTKL3 kinase activity
The sequence encoding the PfTKL3 kinase domain (KD;
see Fig. 1b) was ampliﬁed by PCR from a cDNA library,
expressed as a His6-tagged protein in E. coli, and the
recombinant protein was puriﬁed on nickel beads. Kinase
activity was assessed using non-physiological potential
substrates including myelin basic protein (MBP), histone
H1, and a- and b-casein. Weak activity against MBP and
autophosphorylation were observed only when a high
concentration of the enzyme was used in the kinase assay
(Fig. 7a). In view of published evidence that an accessory
SAM domain can positively regulate the activity of KDs in
other contexts [22], we produced another recombinant
protein that included the SAM domain in addition to
the KD (see Fig. 1b). Only a minute amount of this
His6-tagged SAM-KD protein was recovered (Fig. 7b),
presumably because of low solubility (see below). Never-
theless, kinase activity against MBP was considerably
higher than that yielded by a similar amount of KD alone,
and autophosphorylation was dramatically increased
(Fig. 7c). To verify that the observed activity was due to
the recombinant SAM-KD rather than to co-puriﬁed bac-
terial contaminants, we repeated the experiment with two
‘‘kinase dead’’ mutant versions of the recombinant pro-
teins. These mutants carry a point mutation abolishing
kinase activity (either the change of a conserved Lys in
sub-domain II to Met, or the change of a conserved Asp in
sub-domain VIB to Asn, see Supplemental Fig. S1B).
Reactions conducted with either type of dead mutant did
not yield any signal (Fig. 7d). The active wild-type GST-
KD phosphorylated the inactive His-KD (K ? M) mutant
in a concentration-dependent manner (Fig. 7e), suggesting
PfTKL3 autophosphorylation occurs through an inter-
molecular mechanism.
The effect of 2 mM Mg
2?,M n
2?,C a
2?,C o
2?,N i
2? and
Zn
2? ions (chloride salts) on the activity of the SAM-KD
form of the enzyme was tested. Mn
2? and Co
2? were found
Fig. 4 Visualisation of GFP-tagged PfTKL3 in asexual parasites.
Live asexual cultures from the GFP-tagged line were observed by
ﬂuorescence microscopy. A signal was detected only in the schizont
and free merozoites. A typical image is shown for both these stages. A
49 relative enlargement of a merozoite is shown to the right. Scale
bar: 5 lm
3362 A. Abdi et al.to result in the highest enzymatic activity (Supplemental
Fig. S3).
Site-directed mutagenesis of the PfTKL3 SAM domain
Some SAM domains, such as that in the mammalian
ETV6-NTRK3 chimeric tyrosine kinase (see below), form
an open-ended head-to-tail polymer that is insoluble when
expressed in bacteria; this polymerisation was proposed as
a mechanism for kinase activation (see the ETV6-NTRK3
model in Fig. 8a, adapted from Ref. [23]). If the PfTKL3
SAM domain likewise mediates polymerisation, the
difference in recovery of recombinant KD versus SAM-KD
proteins may thus be caused by a lower solubility of the
latter. Two residues, Ala61 and Val80, are crucial for
polymerisation of the well-characterised ETV6 SAM
domain. The structure of ETV6 SAM consists of ﬁve
helices and has two interacting interfaces: mid-loop (ML)
and end-helix (EH), where Ala61 and Val80 are located,
respectively. The EH valine is conserved in the PfTKL3
SAM domain (V54), while the ML alanine is substituted by
a histidine (H35; Fig. 8b). We mutated these two residues
to glutamate, a residue with opposite properties to those
of valine (which is non-polar) and histidine (which is
Fig. 5 Visualisation of GFP-
tagged PfTKL3 in gametocytes.
A live gametocyte from the
PfTKL-GFP line was observed
by ﬂuorescence microscopy.
Signals were observed
throughout gametocyte
development. See text for
details. Scale bar: 5 lm
A Plasmodium tyrosine kinase-like kinase 3363positively charged), in order to disrupt potential interac-
tions mediated by these amino acids, and expressed the
mutant SAM-KD as His6-tagged recombinant proteins.
Both mutations improved the amount of soluble recombi-
nant protein recovered relative to the wild type, as shown
by Western blot analysis using a rabbit anti-His6 antibody
(Fig. 8c). This was particularly evident with the V54E
mutant, whose yield was sufﬁcient for detection by Coo-
massie staining (Fig. 8c). This suggests that the conserved
Val54 allows the wild-type PfTKL3 SAM domain to form
poorly soluble oligo-/polymers and that mutating this
residue disrupts the interaction, thereby improving the
solubility of the protein.
Self-interaction of the PFTKL3 SAM domain
We cloned and expressed the sequence encoding the SAM
domain (approximately 8 kDa) as recombinant His6-, GST-
and MBP-tagged proteins (Supplemental Fig. 4a). No His6-
tag protein was recovered, either in the soluble or in the
insoluble fractions, while GST-tagged SAM was largely
found in the insoluble fraction (not shown). When the
soluble fraction of the GST-tagged form was subjected to
batch puriﬁcation using glutathione agarose beads, only a
small fraction of the total protein could be eluted, while
most remained in the beads. However, the MBP-tagged
form of PfTKL3 SAM domain was readily expressed in a
soluble form. Pull-down experiments showed that MBP-
SAM is able to interact and pull down GST-SAM from
solution, and vice versa, while the tags alone used as
negative controls were unable to pull down any protein
(Fig. 9 and Fig. S4B).
Discussion
PfTKL3 phylogeny, domain organisation and function
in the life cycle
Our phylogenetic analysis (Fig. 1a) supports the original
classiﬁcation of four plasmodial kinases into the TKL
group. Among those, PfTKL1 and PfTKL3 share overall
Fig. 6 Co-localisation studies.
a An antibody against the
parasitophorous vacuole
membrane protein Pfs16 was
used to counterstain PfTKL3-
GFP expressing gametocytes.
b An anti-tubulin antibody
(anti-TubA) was used to
counterstain PfTKL3-GFP
expressing gametocytes. The
white arrows indicate where the
GFP and TubA signal
concentrate in late stages of
gametocytes. See text for
details. Scale bar: 5 lm
3364 A. Abdi et al.domain organisation, with MORN and SAM motifs
N-terminal to the kinase domain. This organisation is not
seen in any mammalian TKLs. This, together with the
kinase-domain based phylogenetic tree (Fig. 1a) showing
that no human TKL can be identiﬁed as a PfTKL1/3
orthologue, concur to label these enzymes as ‘‘semi-
orphans’’. The Cryptosporidium, N. caninum and T. gondii
kinomes include PfTKL3 orhtologues, suggesting a con-
served function in apicomplexan biology. PfTKL3 being a
‘‘semi-orphan’’ TKL, it is not possible to predict its cellular
function from its sequence. Our reverse genetics data
strongly suggest a crucial role for PfTKL3 in the erythro-
cytic asexual cycle, at least in the in vitro cultivation
system. Elucidation of the cellular process(es) in which the
enzyme functions requires addition work; the development
of a robust inducible expression system for P. falciparum
will represent a major breakthrough for functional analysis
of essential protein kinases.
PfTKL3 was annotated as ‘‘sexual stage-speciﬁc protein
kinase’’ in earlier releases of PlasmoDB, probably because
of the presence of SAM domain: in yeast, cell lines that are
null for proteins containing this 60–70-residue alpha helix-
rich domain cannot undergo sexual differentiation, hence
the name ‘‘sterile a-motif’’. Although all SAM domains
adopt similar folds, they are versatile in their binding
properties: some SAM domains form homodimers or
polymers; others can bind to other SAM domains, to non-
SAM domain-containing proteins and even to RNA
(reviewed in [24]). The number of SAM-containing pro-
teins per organism increases with complexity: yeast has 4,
Drosophila 42 and human 206. P. falciparum has four (as
determined by text scanning of PlasmoDB), two of which,
PfTKL1 and PfTKL3, belong to the TKL group, while the
other two (PFI1275w and PF11_0079) possess a kinase-
like domain lacking residues that are critical for kinase
activity (whether or not these proteins are active kinases
Fig. 7 Kinase activity of recombinant PfTKL3. a Kinase activity of
recombinant His6-PfTKL3 kinase domain (KD); 0.5, 1 or 4 lgo f
His6-PfTKL3-KD wild type was used in a kinase reaction containing
5 lg of myelin basic protein (MBP). Left panel: Coomassie stain of
the gel; right panel: autoradiograph. b Western blot of soluble
PfTKL3 KD and PfTKL3 SAM-KD recovered from 400 ml of
bacterial culture, using an anti-His6 antibody. Equal volumes were
loaded, corresponding to 40 ml of culture. c MBP kinase activity
assay using equal amounts of SAM-KD and KD forms of recombinant
PfTKL3. Top panel: Western blot using an anti-His6 antibody
showing equal loading of both forms of the recombinant enzyme.
Bottom panel: autoradiogram. d Kinase dead-mutant controls. Kinase
assays were performed with the wild-type recombinant SAM-KD
PfTKL3 (lane 3), and with the K ? M( lane 1)o rD? N( lane 2)
kinase-dead mutants using MBP as substrate. Left panel: Coomassie
staining of the gel; right panel: autoradiogram. e Autophosphoryla-
tion in trans: 1 lg of the catalytically inactive His6-tagged (K ? M)
mutant kinase domain was used as a substrate in kinase assay using
increasing amounts of PfTKL3-KD (twofold serial dilutions from the
highest point, which contained 6 lg of active wild-type GST-PfTKL3
KD)
A Plasmodium tyrosine kinase-like kinase 3365remains to be established). The two SAM-containing
TKLs, in addition to their similarity in gene architecture,
also have similar expression proﬁles (micro-array data
available on PlasmoDB) and may possibly interact with
each other via their SAM domain. Pfg27/25 is a gameto-
cyte-speciﬁc phosphoprotein that can speciﬁcally bind
single-stranded RNA [25], a property described for some
SAM domains [26]. Despite a sequence that is distant from
that of typical SAM domains, the Pfg27/25 3D structure
displays SAM domain-like folding and was shown to
undergo phosphorylation-regulated oligomerisation [27].
This suggests Pfg27/25 is an additional P. falciparum SAM
domain-containing protein that may potentially interact
with the kinase-related SAM-domain containing proteins.
Interestingly, all four P. falciparum SAM-domain-
containing protein kinase-like proteins also carry putative
MORN motifs, a feature that, to our knowledge, is not
shared by SAM-containing protein kinases from other
eukaryotes. MORN motifs may be responsible for locali-
sation at the plasma membrane through direct association
with phospholipids [28]. A Toxoplasma gondii protein
that comprises repeated MORN motifs associates with
structures that form the basal complex, the spindle pole
and the apical complex, indicating that MORN motifs,
through interaction with lipids, may be the linking
membranous region to the cytoskeleton [29–31]. In
addition, several MORN motif-containing proteins have
been linked to a role in spermatozoa morphogenesis/bio-
genesis [32, 33]. A role of P. falciparum MORN motif-
containing proteins in the regulation of the cytoskeleton is
a deﬁnite possibility.
The yeast SAM domain-containing Ste11 MAP3K is
essential for mating type differentiation. In Plasmodium,
the switch from asexual replication to gametocytogenesis,
similar to yeast, is induced by stress factors like starvation,
but the signalling pathways involved remain to be identi-
ﬁed. Since PfTKL3 is essential for the asexual stage, it is
not possible to investigate its possible role in this switching
process using the reverse genetics approach we have used
here. Approaches such as conditional knock out, promoter
swap or conditional protein abundance regulation using a
Fig. 8 Mutagenesis of the PfTKL3 SAM domain. a Model for the
stimulation of kinase activity by an adjacent SAM domain. Adapted
from [23]. b Alignment of the SAM domains of ETV6 and PfTKL3.
The ﬁve helices in the secondary structure of ETV6 SAM domain are
shown as grey cylinders. The ETV6 residues and corresponding
PfTKL3 that occur in the interacting interfaces called mid-loop (ML)
H3 and end-helix (EH) H5 are shown in red. Numbering is from the
N-terminal boundary of each SAM domain. c Effect of SAM domain
mutations on the recovery of soluble recombinant SAM-KD PfTKL3.
Top panel: Western blot (anti-His6) of wild-type, V54E and H35E
recovered from 400 ml of bacterial cultures. Bottom panel: The V54E
mutation results in a yield that is sufﬁcient for detection by
Coomassie staining
Fig. 9 MBP-SAM domain pull down assay. Puriﬁed GST-SAM was
incubated with MBP-SAM (lane 1) or MBP alone (lane 2). GST-
SAM was incubated with the lysis buffer as negative control (lane 3).
Amylose-agarose beads were added to the mixture, incubated and
washed. The bound proteins were eluted and subjected to SDS-PAGE
and Western blot analysis. The reciprocal experiment (GST pull-
down assay) and a gel showing the puriﬁed proteins used in this
experiment can be found in Supplemental Fig. S4
3366 A. Abdi et al.destabilisation domain [34] will contribute to the clariﬁ-
cation of the possible role of this protein in sexual
development.
Subcellular localisation
In the gametocyte, especially in stage III, the protein
accumulates in areas that form thread-like structures that
co-localise (or at least closely associate) with a-tubulin,
most likely at the cytoskeleton micro-tubules. The sub-
pellicular membrane complex is said to elongate and
become more prominent in stage II and III gametocytes,
and to localise to one side of the cell only, which is also the
case for PfTKL3. We speculate that PfTKL3 may be
associated with the sub-pellicular membrane complex,
thought to have a role in linking the cytoskeleton micro-
tubules to the pellicle membrane in the gametocytes [21].
This is consistent with the presence of a MORN motif on
PfTKL3: MORN motifs interact with membrane lipids [28]
and have been hypothesised to anchor the cytoskeleton to
membranous structures in the apicomplexan T. gondii [30].
The SAM domains of the transcription factor ETV6, of
DAG-kinase, of Shank3 and of yeast Ste11 have all been
shown to regulate the spatial distribution of their respective
proteins [35–38]. The role of the SAM and MORN
domains in the localisation of PfTKL3 and other P. falci-
parum SAM/MORN-containing proteins warrants further
studies.
Regulation of PfTKL3 enzymatic activity
The activity of recombinant PfTKL3 is dramatically
stimulated by the presence of the accessory SAM domain,
in line with the activation of a PK following translocation
of a SAM domain at its N-terminus (reviewed in [23]).
Our site-directed mutagenesis and pull-down data suggest
that the PfTKL3 SAM domain mediates self-interaction.
Polymer formation may explain the reduced yield of
soluble recombinant protein and increased activity
observed upon addition of the SAM domain. We propose
that the PFTKL3 SAM domain, like its analogue in the
ETV6-NTRK3 chimeric kinase [23] (see Fig. 8a), medi-
ates oligomerisation of the enzyme and thereby generates
a complex where (1) local concentration is very high and
(2) the kinase domains are oriented in a way that facili-
tates trans-autophosphorylation. This is fully consistent
with our observations that PfTKL3 autophosphorylation is
intermolecular (Fig. 7e).
PfTKL3 is a multi-domain protein with the accessory
domains/motifs (14-3-3 mode II, MORN and SAM) that
are potentially implicated in various interactions with lipid,
protein and even RNA. Phosphorylated PfTKL3 residues,
in addition to their role in the regulation of enzymatic
activity, may act as docking pads or anchors for other
proteins, as established for several (especially membrane-
bound) PKs in other contexts (see Refs. [39, 40], for
examples). PfTKL3 may thus act as a hub for a network of
interactions, and it will undoubtedly be fascinating to
identify interacting partners. The disruption of protein-
protein interactions (PPI) is now considered as a target for
chemotherapy [41, 42]. With respect to PfTKL3, which we
validated by reverse genetics as a potential target, the
inhibition of SAM-mediated interactions offers another
opportunity for intervention (in addition to the classical
approach targeting catalytic activity). In the past PPI was
considered to be un-druggable by small molecule inhibitors
because of the often large and featureless interaction
interfaces that lack crevices and pockets. However, in
recent years substantial progress has been made in the
discovery of potent and selective inhibitors of protein-
protein interactions, and such agents are currently in phase
II clinical trial for the treatment of several cancers
(reviewed in [42, 43].
In summary, the facts that PfTKL3 (1) is a functionally
validated target and (2) can be expressed as a strongly
active recombinant protein if the SAM domain is included
justiﬁes earmarking this protein for high-throughput
screening against chemical libraries to identify inhibitory
hits compounds as the ﬁrst step in a drug discovery pro-
gram targeting this enzyme.
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